BiopharmaWatch

FDA/PDUFA Catalyst Calendar | Model Portfolios | Probability of Approval | Options, Earnings, Hedge Fund, and more. #biotech #stocks

[BiopharmaWatch @Biopharma_Watch]

Every upcoming FDA decision and PDUFA date, all in one place:
https://t.co/m7s5aynVNB

[BiopharmaWatch @Biopharma_Watch]

Biotech at the open · Aug 4 🧬

Today's biggest biotech moves, and the catalyst behind each 👇

[BiopharmaWatch @Biopharma_Watch]

▼ $FMS -5.8% · Care accelerates income growth to 23% in the second quarter of 2026 while advancing its strategic agenda
https://t.co/NLv9Ey3biu

[BiopharmaWatch @Biopharma_Watch]

Full FDA and PDUFA calendar, PoA on every name:
https://t.co/6erVJrhN3M

[BiopharmaWatch @Biopharma_Watch]

Upcoming FDA catalysts to watch 🧬

The biggest decisions ahead, with our Probability of Approval on each 👇

[BiopharmaWatch @Biopharma_Watch]

$INO · PoA 70%
INO-3107
Recurrent Respiratory Papillomatosis (RRP)
Catalyst: Oct 30, 2026
https://t.co/6CUJLr2Ihz

[BiopharmaWatch @Biopharma_Watch]

Every upcoming FDA decision and PDUFA date, all in one place:
https://t.co/m7s5aynVNB

[BiopharmaWatch @Biopharma_Watch]

Biotech at the open · Aug 3 🧬

Today's biggest biotech moves, and the catalyst behind each 👇

[BiopharmaWatch @Biopharma_Watch]

▼ $CMND -8.9% · Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company
https://t.co/8zkOLgI5Gr